Innoviva
INVA
200 hedge funds and large institutions have $1.14B invested in Innoviva in 2017 Q3 according to their latest regulatory filings, with 51 funds opening new positions, 66 increasing their positions, 59 reducing their positions, and 14 closing their positions.
264% more first-time investments, than exits
New positions opened: 51 | Existing positions closed: 14
117% more call options, than puts
Call options by funds: $3.67M | Put options by funds: $1.69M
22% more funds holding
Funds holding: 164 → 200 (+36)
17% more capital invested
Capital invested by funds: $974M → $1.14B (+$168M)
12% more repeat investments, than reductions
Existing positions increased: 66 | Existing positions reduced: 59
4.44% more ownership
Funds ownership: 69.58% → 74.01% (+4.4%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Top Buyers
| 1 |
Renaissance Technologies
New York
|
+$14M |
| 2 |
JP Morgan Chase
New York
|
+$9.62M |
| 3 |
Millennium Management
New York
|
+$9.04M |
| 4 |
Morgan Stanley
New York
|
+$6.1M |
| 5 |
RI
Redwood Investments
Boston,
Massachusetts
|
+$5.5M |
Top Sellers
| 1 |
ECP
Empyrean Capital Partners
Los Angeles,
California
|
-$13.5M |
| 2 |
MWNA
Marshall Wace North America
New York
|
-$10.7M |
| 3 |
First Eagle Investment Management
New York
|
-$9.99M |
| 4 |
BlackRock
New York
|
-$6.86M |
| 5 |
State Street
Boston,
Massachusetts
|
-$5.39M |
INVA Hedge Fund Activity: Q3 2017 in Review
200 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Innoviva (INVA) for Q3 2017, worth a combined $1.14B — up 17% from $974M a quarter earlier.
Buyers outnumbered sellers: 51 funds opened new INVA positions and 14 closed out — a net gain of 37 holders — while 66 added to existing stakes and 59 trimmed.
The largest buyer was Renaissance Technologies, opening a new position worth an estimated $14M. The largest seller was Empyrean Capital Partners, cutting an estimated $13.5M.
- 200 institutional investors held Innoviva (INVA) as of Q3 2017, up from 164 in Q2 2017.
- Funds reported $1.14B of Innoviva stock for Q3 2017, up 17% quarter-over-quarter.
- 51 funds opened new Innoviva positions in Q3 2017 and 14 closed out, a net change of +37 holders.
- The largest Innoviva buyer in Q3 2017 was Renaissance Technologies, an estimated $14M added.
- The largest Innoviva seller in Q3 2017 was Empyrean Capital Partners, an estimated $13.5M sold.
Based on aggregated 13F filings for Q3 2017.